Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1

By sjmartinez • August 30, 2023

Schwarzer A, Oliveira M, Kleppa MJ, Slattery SD, Anantha A, Cooper A, Hannink M, Schambach A, Doerrie A, Kotylarov A, Gaestel M, Hembrough T, Levine J, Luther M, Stocum M, Stiles L, Weinstock DM, Liesa M, Kostura MJ. Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1. Mol Cancer Ther. 2023 Aug 30. doi: 10.1158/1535-7163.MCT-22-0718. Epub ahead of print. PMID: 37643767.

Tags: Endocrinology, Publications

Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA

Petrovic I, LoPresti J, Fatemi S, Gianoukakis A, Burman K, Gomez-Lima CJ, Nguyen CT, Spencer CA. Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by[...]

Outcomes of Cytologically Indeterminate Thyroid Nodules Managed With Genomic Sequencing Classifier

Ahmadi S, Kotwal A, Bikas A, Xiang P, Goldner W, Patel A, Hughes EG, Longstaff X, Yeh MW, Livhits MJ. Outcomes of Cytologically Indeterminate Thyroid[...]

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease

Ko M, Barai R, Brent G. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. Cureus. 2024 Oct 15;16(10):e71551. doi: 10.7759/cureus.71551.[...]